Elektrofi is a biotechnology company focused on improving administration for a wide range of medicines including monoclonal antibodies, therapeutic proteins, and other large molecule drugs. Its breakthrough formulation platform enables stabilized, highly concentrated formulations for subcutaneous administration. The company is using this technology to transform therapies that are administered intravenously, and to enhance injectable products by reducing the volume and frequency of dosing. Elektrofi partners with pharmaceutical companies to jointly develop patient-friendly delivery solutions. Headquartered in Boston, the company’s founding team of MIT engineers and scientists are shaping the future of biologics delivery.


Biotechnology

Elektrofi

Chase Coffman

Greg DeFilippis

Chaitanya Sudrik

Paul Herbert

Leo Takaoka

Jason Norris

Paul Brown

Lyndon Charles, Ph.D.

Leadership Team

Research and Development

Operations and Program Management

Teams at Elektrofi

Leadership Team

Research and Development

Operations and Program Management